The committee recommended
Both companies have submitted their plans to the Drugs Controller General of India (DCGI), seeking regulatory approval to proceed
These groundbreaking medications, initially approved for patients with type 2 diabetes, are now revolutionizing chronic disease treatment through their metabolic, hormonal, and anti-inflammatory effects, becoming vital tools in addressing conditions like cardiovascular disease, nonalcoholic fatty liver disease, osteoarthritis, and more
What are the Symptoms of Celiac Disease
Some patients may find compounded semaglutide more affordable than the branded Ozempic
[12] Ghrelin receptors are known for their role in controlling appetite, and their activation may lead to heightened hunger cues, potentially resulting in increased body mass